Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis
Status:
Completed
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
To assess the safety and efficacy of PACK-CXL (photoactivated chromophore for infectious
keratitis cross-linking) as a firstline treatment for infectious corneal infiltrates and
early corneal ulcers, and compare it to the current standard of care, antimicrobial therapy.